Growth Metrics

Dynavax Technologies (DVAX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to -$61000.0.

  • Dynavax Technologies' Cash from Financing Activities fell 10246.37% to -$61000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$202.7 million, marking a year-over-year decrease of 1474158.13%. This contributed to the annual value of -$102.0 million for FY2024, which is 746053.39% down from last year.
  • Dynavax Technologies' Cash from Financing Activities amounted to -$61000.0 in Q3 2025, which was down 10246.37% from -$71.9 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Cash from Financing Activities registered a high of $32.3 million during Q1 2021, and its lowest value of -$98.9 million during Q4 2024.
  • Its 5-year average for Cash from Financing Activities is -$6.8 million, with a median of $1.0 million in 2022.
  • As far as peak fluctuations go, Dynavax Technologies' Cash from Financing Activities surged by 2234848.48% in 2021, and later plummeted by 566728.6% in 2024.
  • Quarter analysis of 5 years shows Dynavax Technologies' Cash from Financing Activities stood at $14.8 million in 2021, then tumbled by 98.97% to $153000.0 in 2022, then surged by 1060.78% to $1.8 million in 2023, then crashed by 5667.29% to -$98.9 million in 2024, then skyrocketed by 99.94% to -$61000.0 in 2025.
  • Its Cash from Financing Activities was -$61000.0 in Q3 2025, compared to -$71.9 million in Q2 2025 and -$31.9 million in Q1 2025.